Skip to main content

SeraCare Seraseq Inherited Cardiomyopathy Reference Material

SeraCare Life Sciences has launched the Seraseq Inherited Cardiomyopathy Reference Material, a multiplexed reference material for hypertrophic cardiomyopathy (HCM) testing by next-generation sequencing. It was developed in collaboration with Birgit Funke, director of clinical research and development at the Partners Healthcare Laboratory for Molecular Medicine. The Seraseq reference material combines ten common pathogenic and/or technically challenging variants for HCM in a well characterized genomic background at a 50 percent target allele frequency, the company said. This is the first testing  control product to be launched after the company's research on testing controls was published online in the Journal of Molecular Diagnostics earlier this year.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.